Orthofix Medical Inc. Common Stock (DE)

The global orthobiologics market is projected to grow from USD 6.68 billion in 2025 to USD 9.52 billion by 2031, with a CAGR of 6.17%. Growth is driven by rising osteoarthritis cases, sports-related injuries, and advancements in regenerative therapies including stem cell therapy and platelet-rich plasma treatments. North America leads the market ...

Orthofix Medical reported Q2 2025 financial results, beating earnings estimates with $203.1 million in revenue, representing 2.3% year-over-year growth. The company saw segment gains in Bone Growth Therapies and Orthopedics, with positive free cash flow and continued new product execution.

The global intramedullary nail market is expected to grow rapidly, driven by the rising incidence of bone fractures, particularly among the aging population, and advancements in surgical techniques. However, the market faces challenges such as high procedural costs, the need for skilled professionals, and competition from alternative fixation dev...

The global prosthetic disc nucleus market is expected to grow significantly, driven by the increasing prevalence of spine disorders and the rising demand for minimally invasive spine surgeries. Key players in the market include Zimmer Biomet, Medtronic, Orthofix Holdings, Spinal Kinetics, and Globus Medical.

A class action lawsuit has been filed against Orthofix Medical Inc. and certain current and former officers and directors, alleging that the offering materials for the merger with SeaSpine Holdings Corporation contained materially false and misleading statements and omissions regarding Orthofix's internal controls and compliance.